Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1985-10-15
1986-11-18
Jiles, Henry R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514369, 546280, 548188, A61K 3144, A61K 31425, C07D40900
Patent
active
046236511
ABSTRACT:
Heterocyclocarbonyl- and acetyl-thiazolones enhance myocardial contractile force and are useful as cardiotonics in the treatment of heart failure.
REFERENCES:
patent: 4405635 (1983-09-01), Schnettler et al.
patent: 4405638 (1983-09-01), Cavazza et al.
Y. Yamamoto, J. Pharm. Soc. Japan 72, 1020 (1952), Abstracted at Chemical Abstracts, vol. 46, cols. 10285-10286.
R. A. Schnettler, 4-Substituted-1,3-Dihydro-2H-Imidazol-2-ones, 187th American Chemical Society National Meeting, Apr. 8-13, '84.
E. Ochiai, J. Pharm. Soc. Japan 60, 164 (1940), Abstracted at Chemical Abstracts, vol. 34, cols. 3449-3450.
Dage Richard C.
Grisar J. Martin
Schnettler Richard A.
Jiles Henry R.
Merrell Dow Pharmaceuticals Inc.
Nesbitt Stephen L.
Whittenbaugh Robert C.
LandOfFree
Cardiotonic heterocyclocarbonyl- and acetyl-thiazolones does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cardiotonic heterocyclocarbonyl- and acetyl-thiazolones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cardiotonic heterocyclocarbonyl- and acetyl-thiazolones will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1617881